Newsletters
The Capitalist Newsletter – January 19, 2017
BRITISH AMERICAN TOBACCO BUYS REYNOLDS AMERICAN FOR $49 BILLION; BUT IS IT A MISTAKE?
|
Winners & Losers – Apricus Biosciences, Inc. (APRI) Soars UP (89.40%) Following Approval of Erectile Dysfunction Drug in Mexico – EnteroMedics, Inc. (ETRM) Continues Plunge DOWN Another (36.85%) After Company Announces Pricing of $16.5 Million Underwritten Public Offering Most Talked About Target Corp. (TGT) Split Down the Middle After Shares Fall DOWN (5.77%) Following Disappointing Holiday Sales and Lowered Guidance The TIP Sheets – Wednesday, January 18th – Netflix, Inc. (NFLX) Ticks UP (0.28%) to After Company Reports its Biggest Quarterly Subscriber Gain Ever. Expect Shares to Continue UP Unusual Volume – CoLucid Pharmaceutical, Inc. (CLCD) Soars UP (32.52%) on 10.9m Shares Traded After Migraine Drug Developer Agrees to be Purchased by Eli Lilly for $960m. Expect Shares to Continue UP |